Vikram Thermo (India) Ltd
BSE:530477
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Vikram Thermo (India) Ltd
Note Receivable
Vikram Thermo (India) Ltd
Note Receivable Peer Comparison
Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors
Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vikram Thermo (India) Ltd
BSE:530477
|
Note Receivable
â‚ą10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Note Receivable
â‚ą3.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Note Receivable
â‚ą4.8B
|
CAGR 3-Years
109%
|
CAGR 5-Years
58%
|
CAGR 10-Years
5%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Note Receivable
â‚ą22.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
8%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Note Receivable
â‚ą1.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-13%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Note Receivable
â‚ą3.1B
|
CAGR 3-Years
75%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
See Also
What is Vikram Thermo (India) Ltd's Note Receivable?
Note Receivable
10m
INR
Based on the financial report for Mar 31, 2024, Vikram Thermo (India) Ltd's Note Receivable amounts to 10m INR.
What is Vikram Thermo (India) Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
21%
Over the last year, the Note Receivable growth was 0%.